当前位置:首页>产品中心>单抗/多抗>Anti-Human DKK4 Polyclonal Antibody|抗人DKK4多克隆抗体(靶标:人Dickkopf相关蛋白4)

Anti-Human DKK4 Polyclonal Antibody|抗人DKK4多克隆抗体(靶标:人Dickkopf相关蛋白4)

  • 货号:RB9THV359014
  • 价格:面议
  • 点击:251

产品介绍

产品参数

形态Liquid
宿主种属Rabbit
克隆性Polyclonal
抗体亚型IgG
纯化方式Purified by antigen affinity column.
内毒素水平Please contact with the lab for this information.
应用ELISA, IHC, WB
种属反应性Human
靶标Dickkopf-related protein 4; Dickkopf-4; Dkk-4; hDkk-4; Dickkopf-related protein 4 short form; DKK4
免疫原E. coli - derived recombinant Human DKK4 (Gln107-His212).
储存缓冲液0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
产品使用说明ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000
登录号Q9UBT3
背景信息

Dickkopf-related protein 4 (DKK4) is a ~24 kDa protein. Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer disease.

备注For research use only
【仅供科学研究使用】

相关产品:
产品名称 点击数
Anti-Isatuximab Non-Neutralizing Recombinant Antibody |抗艾沙妥昔单抗非中和重组抗体(靶标:艾沙妥昔单抗非中和抗体) 284
Anti-Isatuximab Non-Neutralizing Recombinant Antibody |抗艾沙妥昔单抗非中和重组抗体(靶标:艾沙妥昔单抗非中和抗体) 515
Anti-Isatuximab Neutralizing Recombinant Antibody |抗艾沙妥昔单抗中和重组抗体(靶标:艾沙妥昔单抗中和抗体) 403
Anti-Isatuximab Neutralizing Recombinant Antibody |抗艾沙妥昔单抗中和重组抗体(靶标:艾沙妥昔单抗中和抗体) 251
Anti-Isatuximab Neutralizing Recombinant Antibody |抗艾沙妥昔单抗中和重组抗体(靶标:艾沙妥昔单抗中和抗体) 192
Anti-Urelumab Non-Neutralizing Recombinant Antibody |抗乌瑞鲁单抗非中和重组抗体(靶标:乌瑞鲁单抗非中和抗体) 488
Anti-Urelumab Non-Neutralizing Recombinant Antibody |抗乌瑞鲁单抗非中和重组抗体(靶标:乌瑞鲁单抗非中和抗体) 517
Anti-Urelumab Neutralizing Recombinant Antibody |抗乌瑞鲁单抗中和重组抗体(靶标:乌瑞鲁单抗中和抗体) 525
Anti-Urelumab Neutralizing Recombinant Antibody |抗乌瑞鲁单抗中和重组抗体(靶标:乌瑞鲁单抗中和抗体) 524
Anti-Urelumab Neutralizing Recombinant Antibody |抗乌瑞鲁单抗中和重组抗体(靶标:乌瑞鲁单抗中和抗体) 449
Anti-Risankizumab Neutralizing Recombinant Antibody |抗瑞莎珠单抗中和重组抗体(靶标:瑞莎珠单抗中和抗体) 248
Anti-Risankizumab Neutralizing Recombinant Antibody |抗瑞莎珠单抗中和重组抗体(靶标:瑞莎珠单抗中和抗体) 360
Anti-Risankizumab Neutralizing Recombinant Antibody |抗瑞莎珠单抗中和重组抗体(靶标:瑞莎珠单抗中和抗体) 558
Anti-Risankizumab Neutralizing Recombinant Antibody |抗瑞莎珠单抗中和重组抗体(靶标:瑞莎珠单抗中和抗体) 223
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody |抗雷珠单抗非中和重组抗体(靶标:雷珠单抗非中和抗体) 467
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody |抗雷珠单抗非中和重组抗体(靶标:雷珠单抗非中和抗体) 329
Anti-Ranibizumab Non-Neutralizing Recombinant Antibody |抗雷珠单抗非中和重组抗体(靶标:雷珠单抗非中和抗体) 454
Anti-Ranibizumab Neutralizing Recombinant Antibody |抗雷珠单抗中和重组抗体(靶标:雷珠单抗中和抗体) 321
Anti-Ranibizumab Neutralizing Recombinant Antibody |抗雷珠单抗中和重组抗体(靶标:雷珠单抗中和抗体) 430
Anti-Ranibizumab Neutralizing Recombinant Antibody |抗雷珠单抗中和重组抗体(靶标:雷珠单抗中和抗体) 222
总计 33037 个记录,共 1652 页,当前第 1645 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00